{
  "url": "https://openlegislation.uk/human-medicines-coronavirus-and-influenza-amendment-regulations-2020/regulation-16",
  "json_url": "https://openlegislation.uk/human-medicines-coronavirus-and-influenza-amendment-regulations-2020/regulation-16.json",
  "legislation": "uksi/2020/1125",
  "legislation_title": "The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020",
  "legislation_url": "https://openlegislation.uk/human-medicines-coronavirus-and-influenza-amendment-regulations-2020",
  "path": "regulation/16",
  "kind": "regulation",
  "number": "16",
  "heading": "Amendment of regulation 277",
  "text": "In regulation 277 (interpretation), in paragraph (1), at the appropriate place insert—\n““holder of a temporary authorisation” means, where there is in force in relation to a medicinal product an authorisation by the licensing authority on a temporary basis under regulation 174 (but not an authorisation, certificate or registration as mentioned in regulation 279(a) or (b) to (d)), the person who is responsible for placing that product on the market in the United Kingdom;”.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "I",
      "label": "I1",
      "text": "Reg. 16 in force at 6.11.2020, see reg. 1(2)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2020/1125/regulation/16",
    "retrieved_at": "2026-10-28T22:24:22.692849+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}